Jane Street Group, LLC Glaukos Corp Call Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$113.62 - $135.39 $704,444 - $839,417	6,200 New	6,200 $807,000
Q1 2022 May 17, 2022	BUY	$44.33 - $57.82 $2.77 Million - $3.61 Million	62,500 Added 194.7%	94,600 $5.47 Million
Q4 2021 Feb 15, 2022	SELL	$40.27 - $56.99 $833,589 - $1.18 Million	-20,700 Reduced 39.2%	32,100 $1.43 Million
Q3 2021 Nov 16, 2021	BUY	$47.43 - $84.23 $2.3 Million - $4.09 Million	48,500 Added 1127.91%	52,800 $2.54 Million
Q2 2021 Aug 16, 2021	SELL	$73.06 - $97.7 $204,568 - $273,560	-2,800 Reduced 39.44%	4,300 $365,000
Q1 2021 May 18, 2021	BUY	$70.43 - $97.42 $218,333 - $302,002	3,100 Added 77.5%	7,100 $596,000
Q4 2020 Feb 17, 2021	BUY	$48.9 - $75.26 $195,600 - $301,040	4,000 New	4,000 $301,000

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.